Abstract:
Urinary incontinence is not life-threatening, but loss of urinary control can affect the social, psychological, domestic, occupational, physical, and the sexual aspects of patients’ lives. A number of reliable, valid instruments are available for assessing the impact of urinary incontinence on quality of life (QOL). Of these many questionnaires, we selected three, namely, the Bristol Female Lower Urinary Tract Symptoms (BFLUTS) questionnaire, the Incontinence Quality of Life (I-QOL) questionnaire, and the King’s Health Questionnaire (KHQ), and compared the results obtained. These questionnaires have been developed primarily to assess urinary incontinence in women and the impact that urinary incontinence has on aspects of everyday QOL. In the present study, when BFLUTS and I-QOL were compared, the “BFLUTS-IS” and “BFLUTS-QOL” domains were found to correlate inversely with only two and three domains in the I-QOL, respectively. When BFLUTS and the KHQ were compared, the scores of the “BFLUTS-IS” and “BFLUTS-QOL” domains were found to correlate with six domains in the KHQ questionnaire, but these correlations were low to moderate, with correlation coefficients that ranged from 0.412 to 0.649. When I-QOL and the KHQ were compared, “Role limitations” and “Emotional problems” domains in the KHQ were found to correlate with all domains in the I-QOL. Moreover, significant negative correlations were noted between the “Severity measures” domain in the KHQ and all domains in the I-QOL; however, correlations were low to moderate (range: –0.384 to –0.650). Other domains in the three questionnaires showed no correlation with each other. Since a plethora of measurement instruments are available that vary in scope and content, subjective QOL results of urinary incontinence using specific-condition QOL questionnaires may differ. Therefore, before deciding on an instrument, the content on the instrument’s items should be thoroughly reviewed to ensure that a particular aspect of QOL does not need additional assessment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BFLUTS:
-
Bristol female lower urinary tract symptoms
- BFLUTS-FS:
-
BFLUTS filling symptoms
- BFLUTS-IS:
-
BFLUTS incontinence symptoms
- BFLUTS-QOL:
-
BFLUTS quality of life
- BFLUTS-sex:
-
BFLUTS sexual function
- BFLUTS-VS:
-
BFLUTS voiding symptoms
- I-QOL:
-
incontinence quality of life
- KHQ:
-
King’s health questionnaire
- QOL:
-
quality of life
- SF-36:
-
medical outcomes study short form-36
References
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A. (2002). Neurourol Urodyn. 21: 167–178.
Almeida FG, Bruschini H, Srougi M. (2004). J Urol. 171: 1571–1574.
Bidmead J, Cardozo LD, McLellan A, Khullar V, Kelleher CJ. (2001). BJOG. 108: 408–413.
Brookes ST, Donovan JL, Wright M, Jackson S, Abrams P. (2004). Am J Obstet Gynecol 191: 73–82.
Bump RC, Coates KW, Cundiff GW, Harris RL, Weidner AC. (1997). Am J Obstet Gynecol. 177: 303–310.
Bump RC, Norton PA, Zinner NR, Yalcin I. (2003). Duloxetine Urinary Incontinence Study Group Obstet Gynecol. 102: 76–83.
Donovan JL, Abrams P, Peters TJ, Kay HE, Reynard J, Chapple C, De La Rosette JJ, Kondo A. (1996). Br J Urol. 77: 554–562.
Donovan JL, Badia X, Corcos J, Gotoh M, Kelleher C, Naughton M. (2002). In: Abrams P, Cardozo L, Khoury S, Wein A (eds.) Incontinence. Health Publication Ltd, Plymouth, UK, pp. 267–316.
FitzGerald MP, Brubaker L. (2002). Neurourol Urodyn. 21: 30–35.
Frazer MI, Haylen BT, Sutherst JR. (1989). Br J Urol. 63: 14–15.
Grimby A, Milsom I, Molander U, Wiklund I, Ekelund P. (1993). Age Ageing 22: 82–89.
Homma Y, Koyama N. (2006). Neurourol Urodyn. 25: 228–235.
Homma Y, Uemura S. (2004). BJU Int. 93: 1009–1013.
Ho-Yin PL, Man-Wah P, Shing-Kai Yip. (2003). Acta Obstet Gynecol Scand. 82: 275–279.
Hunskaar S, Vinsnes A. (1991). J Am Geriatr Soc. 39: 378–382.
Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. (1996). Br J Urol. 77: 805–812.
Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. (1997). Br J Obstet Gynaecol. 104: 1374–1379.
Kelleher CJ, Pleil AM, Reese PR, Burgess SM, Brodish PH. (2004). Br J Obstet Gynaecol. 111: 605–612.
Lenderking WR, Nackley JF, Anderson RB, Testa MA. (1996). Pharmacoeconomics. 9: 11–23.
Manocchia M, Bayliss MS, Connor J. (1998). SF-36 Health Survey Annotated Bibliography: Second Edition (1988–1996). The Health Assessment Lab, New England Medical Center, Boston, MA.
Nager CW, Schulz JA, Stanton SL, Monga A. (2001). Int Urogynecol J. 12: 395–400.
Naughton MJ, Donovan J, Badia X, Corcos J, Gotoh M, Kelleher C, Lukacs B, Shaw C. (2004). Gastroenterology. 126(Suppl 1): S114–S123.
Nitti VW, Combs AJ. (1996). J Urol. 155: 281–285.
Oh SJ, Ku JH. (2006). Qual Life Res. 15: 493–501.
Oh SJ, Ku JH. (2007). Scand J Urol Nephrol. 41: 66–71.
Patrick DL, Martin ML, Bushnell DM, Yalcin I, Wagner TH, Buesching DP. (1999). Urology. 53: 71–76.
Reid FM, Smith ARB, Dunn G. (2007). Neurourol Urodyn. 26L: 123–128.
Robinson D, Pearce KF, Preisser JS, Dugan E, Suggs PK, Cohen SJ. (1998). Obstet Gynecol. 91: 224–228.
Ross S, Soroka D, Karanhalios A, Glazener CMA, Hay-Smith EJ, Drutz HP. (2006). Int Urogynecol J. 17: 272–285.
Ryhammer AM, Djurhuus JC, Laurberg S, Hermann AP. (1995). Neurourol Urodyn. 14: 456–457.
Sandvik H, Kveine E, Hunskaar S. (1993). Scand J Caring Sci. 7: 53–56.
Simeonova Z, Milsom I, Kullendorff AM, Molander U, Bengtsson C. (1999). Acta Obstet Gynecol Scand. 78: 546–551.
Swift SE, Ostergard DR. (1995). Obstet Gynecol. 85: 704–708.
Symonds T. (2003). Eur Urol. 43: 219–225.
Thomas TM, Plymat KR, Blannin J, Meade TW. (1980). Br Med J. 281: 1243–1245.
Uemura S, Homma Y. (2004). Neurourol. Urodyn. 23: 94–100.
Vandoninck V, Van Balken MR, Finazzi Agro E, Petta F, Caltagirone C, Heesakkers JP, Kiemenev LA, Debruyne FM, Bemelmans BL. (2003). Neurourol Urodyn. 22: 17–23.
Wagner TH, Patrick DL, Bavendam TG, Martin ML, Buesching DP. (1996). Urology. 47: 67–71.
Wyman JF, Harkins SW, Choi SC, Taylor JR, Fantl JA. (1987). Obstet Gynecol. 70: 378–381.
Yalcin I, Patrick DL, Summers K, Kinchen K, Bump RC. (2006). Urology. 67: 1304–1308.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Ku, J.H., Oh, SJ. (2010). Comparison of Three Quality of Life Questionnaires in Urinary Incontinence. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_7
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_7
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine